Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Journal of the National Cancer Institute
|
October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2
Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summary
Peter J Houghton, Peter C Adamson, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study
Julia L Glade Bender, Peter C Adamson, Joel M Reid, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Haematologica
|
June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Tamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2021
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2022
Reply to R. Lakhotia et al
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia
Tamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4
Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescents
Andrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Journal of the National Cancer Institute
|
October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2
Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summary
Peter J Houghton, Peter C Adamson, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study
Julia L Glade Bender, Peter C Adamson, Joel M Reid, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Haematologica
|
June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Tamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2021
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2022
Reply to R. Lakhotia et al
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia
Tamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4
Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescents
Andrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Page
of 18